Search results for "Highlights"
Patient beliefs associated with successful antibiotic treatment of appendicitis
A secondary analysis of a randomized clinical trial found lower risk for appendectomy and higher likelihood of 30-day resolution of signs and symptoms among those who believed that antibiotics could be completely successful versus those who thought they would be unsuccessful or were unsure.
https://gastroenterology.acponline.org/archives/2022/10/28/2.htm
28 Oct 2022
Person-to-person transmission now more common source of hepatitis A in U.S. than food
An analysis of hepatitis outbreaks in 2016 to 2020, comprising 37,553 cases, found that 56% of patients reported drug use, 14% reported homelessness, 12% reported recent incarceration, and 3% reported recent international travel.
https://gastroenterology.acponline.org/archives/2022/10/28/1.htm
28 Oct 2022
IV iron regimens compared for serum phosphate effects in patients with IBD
Ferric carboxymaltose and ferric derisomaltose worked well to resolve anemia from inflammatory bowel disease (IBD), but the former was associated with low serum phosphate levels, according to an industry-funded trial.
https://gastroenterology.acponline.org/archives/2022/09/23/2.htm
23 Sep 2022
High consumption of ultra-processed foods associated with CRC in men
Among women, only consumption of ready-to-eat or -heat mixed dishes was linked to increased risk of colorectal cancer (CRC), according to a new analysis of the Health Professionals Follow-up Study and Nurses' Health Studies.
https://gastroenterology.acponline.org/archives/2022/09/23/3.htm
23 Sep 2022
Self-administered questionnaire may help evaluate patients' cirrhosis knowledge
The questionnaire, which covered medication use and accessibility, medication obstacles, lactulose use, diuretic use, beta-blocker use, and dietary sodium use, was validated in a study of 582 outpatients and 131 inpatients.
https://gastroenterology.acponline.org/archives/2022/09/23/1.htm
23 Sep 2022
Heart failure risk increased in patients with NAFLD, meta-analysis finds
Nonalcoholic fatty liver disease (NAFLD) was associated with a 50% increased risk of new-onset heart failure, independent of age, sex, diabetes, hypertension, and other common cardiovascular risk factors, according to an international meta-analysis.
https://gastroenterology.acponline.org/archives/2022/08/26/2.htm
26 Aug 2022
HCV treatment effective, but underutilized, studies show
One study found that re-infection rates are low after successful hepatitis C virus (HCV) treatment in people who inject drugs, while another found that use of direct-acting antivirals in patients diagnosed with HCV is low, regardless of insurance status.
https://gastroenterology.acponline.org/archives/2022/08/26/3.htm
26 Aug 2022
GI bleeding risks with warfarin and DOACs compared
Warfarin was associated with a similar risk of lower GI bleeding as direct oral anticoagulants (DOACs) but more than twice the rate of upper GI bleeding, which led study authors to suggest that DOACs may be preferable to warfarin in patients at high risk of upper GI bleeds.
https://gastroenterology.acponline.org/archives/2022/08/26/1.htm
26 Aug 2022
Fatty liver disease may not affect mortality risk in elderly patients
In a Dutch cohort study of patients ages 65 years and older, no association was found between hepatic steatosis and death in the overall population or in clinically relevant subgroups.
https://gastroenterology.acponline.org/archives/2022/07/22/3.htm
22 Jul 2022
DPP-4 inhibitors associated with risk of cholecystitis, meta-analysis finds
Patients with type 2 diabetes who were randomized to receive dipeptidyl peptidase-4 (DPP-4) inhibitors had higher rates of gallbladder disease than those who got placebo or nonincretin drugs, but no difference in risk of cholelithiasis or biliary diseases.
https://gastroenterology.acponline.org/archives/2022/07/22/6.htm
22 Jul 2022